tiprankstipranks
Trending News
More News >
Ritamix Global Limited (HK:1936)
:1936
Hong Kong Market

Ritamix Global Limited (1936) AI Stock Analysis

Compare
2 Followers

Top Page

HK

Ritamix Global Limited

(1936)

Rating:55Neutral
Price Target:
Ritamix Global Limited's stock score is influenced predominantly by its financial performance and technical indicators. The company's strong equity position and low leverage are positive, but declining profitability and cash flow volatility are significant concerns. Technically, the stock is showing bearish signs, with downward momentum and trading below key moving averages. Valuation is moderate, with a P/E ratio slightly above the industry average, but the lack of a dividend yield reduces appeal.

Ritamix Global Limited (1936) vs. iShares MSCI Hong Kong ETF (EWH)

Ritamix Global Limited Business Overview & Revenue Model

Company DescriptionRitamix Global Limited (1936) is a company operating in the animal nutrition and health industry. It engages in the development, manufacture, and distribution of a range of animal feed additives and agricultural products. The company's core offerings include premixes, specialty feed additives, and animal health products, which are designed to enhance livestock productivity and health.
How the Company Makes MoneyRitamix Global Limited generates revenue through the sale of its animal feed additives and health products to agricultural businesses, livestock farms, and distributors. The company's key revenue streams include direct sales of premixes and specialty additives, which are used to improve the nutritional value of animal feed and promote better health outcomes in livestock. Additionally, Ritamix Global may engage in strategic partnerships with agricultural companies and distributors to expand its market reach and product distribution network, thereby contributing to its revenue growth.

Ritamix Global Limited Financial Statement Overview

Summary
Ritamix Global Limited shows financial stability with a strong equity base and low leverage, but faces challenges with declining revenue and margins, as well as volatile cash flows. The company's ability to stabilize cash flow and improve profitability is crucial.
Income Statement
55
Neutral
The company's revenue has shown inconsistent growth over the years, with a noticeable decline in 2023. Gross Profit Margin and Net Profit Margin have been relatively stable, but both have decreased in the most recent year. This suggests challenges in maintaining cost efficiency or pricing power. The EBIT and EBITDA margins have also declined, indicating reduced operational profitability.
Balance Sheet
68
Positive
The company maintains a strong equity base with a low Debt-to-Equity Ratio, reflecting solid financial stability and low leverage risk. The Equity Ratio remains robust, further emphasizing the company's reliance on equity financing. However, the Return on Equity has decreased recently, suggesting potential inefficiencies in utilizing shareholder capital.
Cash Flow
45
Neutral
The company's free cash flow has been volatile, with a significant drop in the latest period. The absence of operating cash flow in the most recent year is concerning, as it indicates potential issues in generating cash from core operations. This unpredictability poses risks to the company's financial flexibility and ability to fund operations or expansions.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
122.53M117.80M134.18M120.14M115.88M
Gross Profit
25.77M26.12M31.95M27.91M26.12M
EBIT
6.22M11.41M16.53M16.19M12.55M
EBITDA
7.24M12.43M18.40M17.77M13.89M
Net Income Common Stockholders
8.28M11.42M11.31M11.84M8.45M
Balance SheetCash, Cash Equivalents and Short-Term Investments
95.07M88.22M74.40M55.00M68.25M
Total Assets
174.89M170.51M159.14M153.88M149.02M
Total Debt
1.89M1.88M87.00K122.00K61.00K
Net Debt
-58.43M-54.57M-43.84M-11.54M-15.11M
Total Liabilities
41.18M10.35M10.54M13.20M8.31M
Stockholders Equity
134.66M160.58M148.60M140.68M140.71M
Cash FlowFree Cash Flow
0.0014.55M24.08M3.43M8.21M
Operating Cash Flow
0.0015.25M24.79M4.18M9.52M
Investing Cash Flow
0.00-1.84M8.22M6.61M-50.45M
Financing Cash Flow
0.00-886.00K-756.00K-14.30M49.63M

Ritamix Global Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.56
Price Trends
50DMA
0.61
Negative
100DMA
0.64
Negative
200DMA
0.61
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
39.53
Neutral
STOCH
11.11
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1936, the sentiment is Negative. The current price of 0.56 is below the 20-day moving average (MA) of 0.61, below the 50-day MA of 0.61, and below the 200-day MA of 0.61, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.53 is Neutral, neither overbought nor oversold. The STOCH value of 11.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1936.

Ritamix Global Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$8.82B14.914.71%6.22%3.60%-2.66%
55
Neutral
HK$264.32M18.675.56%3.45%-27.71%
50
Neutral
$2.38B-0.99%15.01%-0.16%-189.58%
46
Neutral
HK$189.57M-26.80%-6.09%66.59%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1936
Ritamix Global Limited
0.58
0.02
3.57%
HK:1498
PuraPharm Corp. Ltd.
0.48
-0.24
-33.33%
HK:3818
China Dongxiang (Group) Co
0.41
0.07
21.99%

Ritamix Global Limited Corporate Events

Ritamix Global Limited Announces 2025 Annual General Meeting
Apr 25, 2025

Ritamix Global Limited has announced its upcoming annual general meeting (AGM) scheduled for June 25, 2025, in Malaysia, with electronic facilitation. The AGM will address several key resolutions, including the adoption of the audited financial statements for 2024, re-election of directors, and re-appointment of the independent auditor. Additionally, the meeting will consider authorizing the board to allot and issue additional shares, which could impact the company’s capital structure and shareholder value.

Ritamix Global Limited Reports 2024 Financial Results
Mar 28, 2025

Ritamix Global Limited announced its audited consolidated financial results for the year ending December 31, 2024. The company reported a slight increase in revenue to RM122,534,000 compared to RM117,797,000 in 2023, but experienced a decrease in profit before tax to RM11,461,000 from RM15,024,000. The total comprehensive income for the year was RM5,057,000, down from RM11,557,000 in the previous year, indicating challenges in maintaining profitability despite revenue growth.

Ritamix Global Limited Issues Profit Warning with Revised Estimates
Mar 26, 2025

Ritamix Global Limited has issued a supplementary announcement regarding a profit warning for the financial year. The company expects a decrease in profit attributable to equity owners, estimated between RM8.0 million and RM8.5 million, compared to RM11.4 million in the previous year. This adjustment is primarily due to an impairment adjustment reflecting changes in the fair value of unquoted equity shares and a decline in sales within its manufacturing business.

Ritamix Global Limited Issues Profit Warning Amid Financial Challenges
Mar 18, 2025

Ritamix Global Limited has issued a profit warning, indicating a significant decrease in profit for the financial year ending 31 December 2024, with expected profits dropping to no more than RM6.0 million from approximately RM11.4 million the previous year. This decline is attributed to increased project development expenses, decreased sales due to weaker market demand and competitive pressures, and an impairment adjustment for unquoted equity shares. The company advises caution to shareholders and potential investors as the final audited results may differ from the preliminary figures.

Ritamix Global Limited Schedules Board Meeting for Annual Results and Dividend Decision
Mar 17, 2025

Ritamix Global Limited has announced that its board of directors will meet on March 28, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. The board will also discuss the potential declaration of a final dividend. This meeting is significant as it will determine the company’s financial performance and shareholder returns, impacting its market positioning and stakeholder interests.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.